Chitotriosidase activity in plasma and mononuclear and polymorphonuclear leukocyte populations
Authors:
- 1 January 2003
- journal article
- research article
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 17 (6) , 271-275
Abstract
In the general population, about 5% of individuals are homozygotic and 35% are heterozygotic carriers for chitotriosidase (ChT) deficiency. Activated macrophages are considered to be the main source of plasma ChT activity, which permits the biochemical characterization of homozygote deficients. However, in the case of detecting heterozygotic carriers, the results are often inconclusive. The activities of ChT in plasma and mononuclear (MN) and polymorphonuclear (PMN) leukocytes were determined in 169 control subjects (72 males and 97 females) with a mean age (± SD) of 47.5±9.7 years (range 18–96 years). The specific enzyme activity was in PMN leukocytes >MN leukocytes >plasma, with a highly significant partial correlation being found between the activities of ChT in plasma and PMN leukocytes (r=0.578, PP<0.001). No significant correlation was found for enzyme activities in MN (r=0.105) or in PMN leukocytes (r=0.043). The results obtained suggest that, in normal physiological conditions, PMN leukocytes may secrete ChT to the plasma. Although the activities of ChT in MN and PMN leukocytes are not affected by demographic factors, it is not possible to use them for the biochemical detection of ChT‐deficient heterozygotic carriers. J. Clin. Lab. Anal. 17:271–275, 2003.Keywords
This publication has 17 references indexed in Scilit:
- Plasma chitotriosidase activity in acute Plasmodium falciparum malariaClinica Chimica Acta, 2003
- Thermodynamic determination of β-hexosaminidase isoenzymes in mononuclear and polymorphonuclear leukocyte populationsAmerican Journal of Medical Genetics Part A, 2002
- Relationships between Serum Markers of Monocyte/Macrophage Activation in Type 1 Gaucher's DiseaseClinical Chemistry and Laboratory Medicine (CCLM), 2002
- Plasma Chitotriosidase Activity Is a Marker of Recovery in Transplanted Patients Affected by β-Thalassemia majorActa Haematologica, 2001
- Chitotriosidase genotype and serum activity in subjects with combined hyperlipidemia: Effect of the lipid-lowering agents, atorvastatin and bezafibrateMetabolism, 2001
- Identification of a Novel Acidic Mammalian Chitinase Distinct from ChitotriosidaseJournal of Biological Chemistry, 2001
- Plasma Chitotriosidase Activity in Patients with β-ThalassemiaBlood Cells, Molecules, and Diseases, 1999
- Synthesis, Sorting, and Processing into Distinct Isoforms of Human Macrophage ChitotriosidaseEuropean Journal of Biochemistry, 1997
- Cloning of a cDNA Encoding Chitotriosidase, a Human Chitinase Produced by MacrophagesJournal of Biological Chemistry, 1995
- Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease.Journal of Clinical Investigation, 1994